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Introduction: The aim of this study was to evaluate the influence of biotransformation 
enzymes and enzymes of multidrug resistance for the prognosis and effects of chemotherapy 
of breast cancer patients. The first part dealed with the genetic factors and the influence of 
genetic polymorphisms in selected biotransformation ge es and in ABCB1 gene and their 
influence in the formation and prognosis of breast cancer. In the second part, the expression 
profiles of these genes were analyzed as potential prognostic and predictive properties of a 
treatment’s outcome. 
Materials and methods: Polymorphisms of biotransformation genes were determined using 
real-time PCR and polymorphisms of ABCB1 gene were determined using NanoChip Assay, 
which was performed in our cooperated department. In both cases, the polymorphisms were 
detected in DNA obtained from the blood of patients. The expression of genes was 
determined using quantitative real-time PCR in paired tumor and adjacent non-tumor tissue of 
breast cancer samples. The expression of NQO1 and p53 protein was assesed by 
immunohistochemistry in the tumor breast tissues.  
Results: The frequencies of the studied SNPs did not differ rom the previous published 
results, however SNP SOD3 rs1799895 was interesting because only ancestral allele were 
found. In the first study significant association fr gene NQO1 were found, but there were not 
confirmed by validation study or subsequent extended study. The significant association was 
found for NQO2 Leu allele of SNP rs1143684, which was associated with lower stadium of 
disease and with better prognosis of disease. SOD2 genotype Ala/Ala of SNP rs4880 was 
associated with worse PFS in the treatment of cyclophoshamide without hormonal therapy 
outcome. Also significant association with PFS and SOD3 SNP rs699473 was found, where 
worse PFS was related to presence of non-ancestral allele and hormonal treatment outcome 
(tamoxifen or aromatase inhibitor). For gene ABCB1 significant association was found 
between non-ancestral allele of SNPs rs1128503 and rs1045642 and ER expression, which 
was not more often found in tumor tissues samples. In expression study of CYPs the highest 
expression was found for gene CYP1B1. 
Conclusions: Our results from first two studies suggested the importance of including of 
validation sets into the performed studies or the verification of the results on the larger 
number of samples, which were initially performed on a small number of samples. According 
to our studies of biotransformation enzymes (especially genes CYP2E1 and CYP1B1) and 
enzymes modifying oxidative stress (especially genes SOD2 and SOD3) seem to be promising 
prognostic markers in the future targeted therapy of breast carcinomas. The most interesting 
polymorphisms in ABCB1 seem to be SNPs in exon 12 and 26 for the next study of the 
resistence of breast cancer. 
 
